|
|
|
There is no vaccine currently licensed in the US for use in infants. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected.] Centers for Disease Control and Prevention. [5. Additionally, based on its mechanism, it is believed that the compound may potentially protect against exposure to chlorine gas.
ativan vs xanax lorazepam xanax peak time for xanax to work xanax convulsions xanax mixed with tussionex suspension xanax side effects paranoia xanax with effexor xanax yellow pills dosage
No new clinical trials are required, and it is expected that Novartis will be able to respond to all questions fully in 2009. Serogroups B and C are predominant in Europe. While Asia has primarily seen serogroup A, recent outbreaks of serogroup C have been noted. There can be no guarantee that Menveo will be approved for sale in any market. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools and consumer health products. [5.D. Ph. The FDA has a special “Animal Rule” under which compounds may be approved for use against chemical and nuclear threats on the strength of animal efficacy studies, which allows the potential for an accelerated approval path versus conventional pharmaceutical applications.
|
|
No News has been posted yet
|
|
|
Forgotten your password? Request a new one here.
|
 Guests Online: 1
No Members Online
Registered Members: 1
Unactivated Members: 0
Newest Member: Owen Electrical
|
|
v6.01.1 © 2003-2005